Abstract
The life cycle of the malaria parasite Plasmodium is complex with distinct phases occurring in the human host and the mosquito vector. Proliferation of asexual parasites within blood cells leads to pathology whereas a distinct sexual stage is required to mediate transmission to the insect. There is a surprising lack of information about how progression of the life cycle is controlled. By analogy with other systems, it is likely that differentiation is regulated by intracellular signalling cascades involving specific phosphorylation/dephosphorylation events. Following an early report in the literature suggesting a role for the parasite cGMP signalling pathway in male gametogenesis, our recent work has investigated the role of the P. falciparum cGMP-dependent protein kinase (PfPKG) in the parasite life cycle. We have used specific inhibitors of the parasite PKG in conjunction with transgenic parasites expressing an inhibitor-insensitive PfPKG to provide direct evidence of a role for this kinase in gametogenesis [1]. Furthermore, we have used this approach recently to elucidate a central role for PfPKG in the late events of P. falciparum asexual blood stage schizogony. Using the P. berghei mouse malaria model we have also demonstrated a role for the kinase in gliding motility of the ookinete; the zygote form that borrows through the insect midgut wall. Discovery of essential functions for PfPKG in multiple developmental stages suggest that it may be a good target for new anti-malarial drugs.
Highlights
Louisa McRobert1, Helen M Taylor2, Cathy J Taylor1, Wensheng Deng1, Robert W Moon3,4, Quinton L Fivelman1, Munira Grainger3, Spencer D Polley1, Audrey Sicard2, Oliver Billker4, Anthony A Holder3 and
4th International Conference of cGMP Generators, Effectors and Therapeutic Implications Meeting abstracts – A single PDF containing all abstracts in this Supplement is available here. http://www.biomedcentral.com/content/pdf/1471-2210-9-S1-info.pdf
The life cycle of the malaria parasite Plasmodium is complex with distinct phases occurring in the human host and the mosquito vector
Summary
Louisa McRobert1, Helen M Taylor2, Cathy J Taylor1, Wensheng Deng1, Robert W Moon3,4, Quinton L Fivelman1, Munira Grainger3, Spencer D Polley1, Audrey Sicard2, Oliver Billker4, Anthony A Holder3 and. Address: 1London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK, 2Wellcome Centre for Molecular Parasitology, University of Glasgow, Glasgow, G12 8TA, UK, 3Medical Research Council National Institute for Medical Research, Mill Hill, London NW7 1AA, UK and 4Wellcome Trust Sanger Institute, Cambridge Hinxton, CB10 1SA, UK Email: David A Baker* - david.baker@lshtm.ac.uk * Corresponding author from 4th International Conference of cGMP Generators, Effectors and Therapeutic Implications Regensburg, Germany.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.